Eli Lilly (NYSE:LLY) shares traded in the red on Wednesday, breaking a streak of six straight days of gains. Stock closed ...
Google stock is a mutual fund favorite and is near a buy point. Two other leading growth stocks top the list of fund favorites.
Eli Lilly & Co.’s hefty investment in expanding production capacity for its popular weight-loss and diabetes drugs is ...
Eli Lilly announced impressive Q1 2024 financial results, with revenue surging by 26% YoY and exceeding expectations for earnings per share. The company raised its full-year 2024 revenue guidance ...
Tirzepatide sales are off the charts but could be much higher if not for supply constraints. Eli Lilly will invest $9 billion in a manufacturing facility to keep up with demand for its weight ...
Glencar has taken over the construction of a life sciences building near Cambridge from collapsed contractor Readie. Readie ...
20-year-old charged for allegedly jumping 78-year-old man with dementia, police say Olive oil may lower your risk of dementia ...
Alphabet has announced who its new chief financial officer (CFO) will be, revealing today that it has hired pharmaceutical giant Eli Lilly and Company's CFO Anat Ashkenazi. Ashkenazi will start her ...
The Price to Earnings ratio of 120.04 for this company is 1.74x above the industry average, indicating a premium valuation associated with the stock. It could be trading at a premium in relation ...
QurAlis granted Lilly an exclusive, worldwide license to develop and commercialize QRL-204. The agreement includes a research and development collaboration to identify and develop additional ...
The incident comes after a series of official investigations last year related to the issuance of fake birth certificates at a time when China is trying to boost its birth rate. Cardinal now expects ...